Serina Therapeutics, Inc.
SER
$5.70
-$0.15-2.56%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -14.00K | 14.00K | 51.00K | 5.00K | 3.09M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.00K | 14.00K | 51.00K | 5.00K | 3.09M |
| Cost of Revenue | 2.37M | 2.42M | 1.59M | 1.11M | 907.00K |
| Gross Profit | -2.38M | -2.40M | -1.54M | -1.10M | 2.18M |
| SG&A Expenses | 1.69M | 2.91M | 2.32M | 1.22M | 340.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.06M | 5.33M | 3.92M | 2.33M | 1.25M |
| Operating Income | -4.07M | -5.31M | -3.87M | -2.32M | 1.84M |
| Income Before Tax | -2.75M | 1.38M | 5.18M | -15.02M | 1.05M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.75M | 1.38M | 5.18M | -15.02M | 1.05M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 12.00K | 27.00K | 27.00K | 0.00 | -- |
| Net Income | -2.74M | 1.41M | 5.20M | -15.02M | 1.05M |
| EBIT | -4.07M | -5.31M | -3.87M | -2.32M | 1.84M |
| EBITDA | -4.02M | -5.26M | -3.81M | -2.30M | 1.85M |
| EPS Basic | -0.59 | 0.16 | 0.61 | -5.38 | 0.44 |
| Normalized Basic EPS | -0.17 | 0.10 | 0.38 | -1.79 | 0.46 |
| EPS Diluted | -0.30 | 0.13 | 0.51 | -5.38 | 0.16 |
| Normalized Diluted EPS | -0.17 | 0.08 | 0.32 | -1.79 | 0.16 |
| Average Basic Shares Outstanding | 18.54M | 8.85M | 8.51M | 2.79M | 2.41M |
| Average Diluted Shares Outstanding | 18.54M | 10.75M | 10.16M | 2.79M | 6.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |